Hologic, Inc. [HOLX] stock is trading at $78.10, down -0.36%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HOLX shares have lost -0.46% over the last week, with a monthly amount glided 6.88%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Hologic, Inc. [NASDAQ: HOLX] stock has seen the most recent analyst activity on June 27, 2024, when Stephens initiated its Overweight rating and assigned the stock a price target of $87. Previously, Citigroup upgraded its rating to Buy on April 03, 2024, and elevated its price target to $95. On July 14, 2023, upgrade upgraded it’s rating to Buy but maintained its price target of $95 on the stock. RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and suggested a price target of $75 on December 07, 2022. Mizuho initiated its recommendation with a Buy and recommended $75 as its price target on October 13, 2022. UBS started tracking with a Neutral rating for this stock on July 20, 2022, and assigned it a price target of $73. In a note dated July 20, 2022, BofA Securities downgraded an Neutral rating on this stock and revised its target price from $81 to $75.
Hologic, Inc. [HOLX] stock has fluctuated between $64.02 and $82.45 over the past year. Currently, Wall Street analysts expect the stock to reach $78 within the next 12 months. Hologic, Inc. [NASDAQ: HOLX] shares were valued at $78.10 at the most recent close of the market. An investor can expect a potential drop of -0.13% based on the average HOLX price forecast.
Analyzing the HOLX fundamentals
Hologic, Inc. [NASDAQ:HOLX] reported sales of 3.96B for the trailing twelve months, which represents a drop of -0.85%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.09 and Total Capital is 0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 77.85 points at the first support level, and at 77.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 78.52, and for the 2nd resistance point, it is at 78.95.
Ratios To Look Out For
For context, Hologic, Inc.’s Current Ratio is 3.97. Also, the Quick Ratio is 3.29, while the Cash Ratio stands at 2.28. Considering the valuation of this stock, the price to sales ratio is 4.60, the price to book ratio is 3.76 and price to earnings (TTM) ratio is 40.18.
Transactions by insiders
Recent insider trading involved Stamoulis Christiana, Director, that happened on Jul 17 ’24 when 9039.0 shares were sold. Chairman, President and CEO, MACMILLAN STEPHEN P completed a deal on Jul 17 ’24 to sell 3672.0 shares. Meanwhile, Director GARRETT SCOTT T sold 16441.0 shares on Mar 14 ’24.
